Arbutus Biopharma Corp Increase (Decrease) in Unbilled Receivables
Arbutus Biopharma Corp (ABUS) reported Increase (Decrease) in Unbilled Receivables of -$128.00 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-03.
Discontinued › Notes
us-gaap:IncreaseDecreaseInUnbilledReceivables · last filed 2018-08-03
CAD
| Period end | Increase (Decrease) in Unbilled Receivables 12 month |
|---|---|
| 2012-12-31 | 2.18M CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | -632.11K CAD 20-F · filed 2013-03-27 |
| 2010-12-31 | 817.46K CAD 20-F · filed 2013-03-27 |
USD
| Period end | Increase (Decrease) in Unbilled Receivables 3 month | Increase (Decrease) in Unbilled Receivables 3 month as first filed | Increase (Decrease) in Unbilled Receivables 6 month | Increase (Decrease) in Unbilled Receivables 9 month | Increase (Decrease) in Unbilled Receivables 12 month | Increase (Decrease) in Unbilled Receivables 12 month as first filed |
|---|---|---|---|---|---|---|
| 2018-06-30 | -$128.00K 10-Q · filed 2018-08-03 | -$128.00K 10-Q · filed 2018-08-03 | ||||
| 2017-12-31 | $0.00 10-K · filed 2018-03-16 | |||||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-03 | $0.00 10-Q · filed 2018-08-03 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | $0.00 10-K · filed 2018-03-16 | ||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | -$335.00K derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-04 | $0.00 10-Q · filed 2016-08-04 | -$335.00K derived: sum of 3 quarters · filed 2018-03-16 | -$171.00K derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-04 | -$335.00K derived: sum of 2 quarters · filed 2018-03-16 | -$171.00K derived: sum of 3 quarters · filed 2018-03-16 | -$1.48M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2015-12-31 | -$335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$171.00K derived: sum of 2 quarters · filed 2018-03-16 | -$1.48M derived: sum of 3 quarters · filed 2018-03-16 | -$349.00K 10-K · filed 2018-03-16 | ||
| 2015-09-30 | $164.00K 10-Q · filed 2016-11-03 | -$1.14M derived: sum of 2 quarters · filed 2016-11-03 | -$14.00K 10-Q · filed 2016-11-03 | $397.00K derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2015-06-30 | -$1.30M 10-Q · filed 2016-08-04 | -$178.00K 10-Q · filed 2016-08-04 | $233.00K derived: sum of 3 quarters · filed 2017-03-22 | $194.00K derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2015-03-31 | $1.13M 10-Q · filed 2016-05-04 | $1.54M derived: sum of 2 quarters · filed 2017-03-22 | $1.50M derived: sum of 3 quarters · filed 2017-03-22 | $1.28M derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2014-12-31 | $411.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $372.00K derived: sum of 2 quarters · filed 2017-03-22 | $152.00K derived: sum of 3 quarters · filed 2017-03-22 | $360.00K 10-K · filed 2017-03-22 | ||
| 2014-09-30 | -$39.00K 10-Q · filed 2015-11-05 | -$259.00K derived: sum of 2 quarters · filed 2015-11-05 | -$51.00K 10-Q · filed 2015-11-05 | -$897.00K derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2014-06-30 | -$220.00K 10-Q · filed 2015-08-07 | -$12.00K 10-Q · filed 2015-08-07 | -$858.00K derived: sum of 3 quarters · filed 2016-03-09 | -$2.84M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2014-03-31 | $208.00K 10-Q · filed 2015-05-06 | -$638.00K derived: sum of 2 quarters · filed 2016-03-09 | -$2.62M derived: sum of 3 quarters · filed 2016-03-09 | -$4.60M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2013-12-31 | -$846.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | -$2.83M derived: sum of 2 quarters · filed 2016-03-09 | -$4.81M derived: sum of 3 quarters · filed 2016-03-09 | -$2.01M 10-K · filed 2016-03-09 | -$2.01M 6-K · filed 2014-03-06 | |
| 2013-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$3.96M derived: sum of 2 quarters · filed 2014-11-07 | -$1.16M 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | -$1.98M 10-Q · filed 2014-11-07 | -$287.00K 10-Q · filed 2014-08-14 | $819.00K 10-Q · filed 2014-08-14 | |||
| 2013-03-31 | $1.11M 10-Q · filed 2014-05-14 | |||||
| 2012-12-31 | $2.19M 10-K · filed 2015-03-13 | $2.19M 6-K · filed 2014-03-06 | ||||
| 2011-12-31 | -$621.55K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |